Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
Gynecologic Oncology|December 10, 2016
Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcomaKoji Matsuo, Malcolm S Ross, Stephen H Bush, et al.
Journal of Surgical Oncology|October 19, 2017
Survival outcome of women with stage IV uterine carcinosarcoma who received neoadjuvant chemotherapy followed by surgeryKoji Matsuo, Marian S Johnson, Dwight D Im, et al.
Gynecologic Oncology|December 18, 2017
Significance of venous thromboembolism in women with uterine carcinosarcomaKoji Matsuo, Malcolm S Ross, Dwight D Im, et al.
Gynecologic Oncology|February 21, 2017
Impact of adjuvant therapy on recurrence patterns in stage I uterine carcinosarcomaKoji Matsuo, Kohei Omatsu, Malcolm S Ross, et al.
Gynecologic Oncology|October 24, 2017
Salvage chemotherapy with taxane and platinum for women with recurrent uterine carcinosarcomaKoji Matsuo, Malcolm S Ross, Mayu Yunokawa, et al.
Surgical Oncology|June 15, 2019
Tumor characteristics and outcome of uterine carcinosarcoma in women aged ≥80 yearsKoji Matsuo, Malcolm S Ross, Mayu Yunokawa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2021
Nivolumab Versus Gemcitabine or Pegylated Liposomal Doxorubicin for Patients With Platinum-Resistant Ovarian Cancer: Open-Label, Randomized Trial in Japan (NINJA)Junzo Hamanishi, Nobuhiro Takeshima, Noriyuki Katsumata, et al.
Annals of Surgical Oncology|July 5, 2018
Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine CarcinosarcomaKoji Matsuo, Yutaka Takazawa, Malcolm S Ross, et al.
Surgical Oncology|September 16, 2018
Characterizing sarcoma dominance pattern in uterine carcinosarcoma: Homologous versus heterologous elementKoji Matsuo, Yutaka Takazawa, Malcolm S Ross, et al.
Pageof 37